What the changes say
- The company added significant risks regarding its new Solana treasury strategy, governance, and validator operations, while dropping industrial hemp and CBD regulatory risks.
What changed since the prior 10-K
New
- NewRisks Related to Upexi
We are eligible to be treated as a “smaller reporting company” within the meaning of the Securities Act, and we cannot be certain if the reduced disclosure requirements applicable to smaller reporting companies will make our common stock less attractive to investors
We are eligible to be a smaller reporting company, which may reduce our disclosure requirements and make our stock less attractive.
- NewRisks Relating to Investing in Solana
Fluctuations in the price of Solana may significantly influence the market price of our common stock
Fluctuations in the volatile price of Solana, which traded between $60 and $253, may significantly influence our common stock price.
- NewRisks Relating to Investing in Solana
A significant decrease in the market value of our Solana could adversely affect our ability to satisfy our financial obligations
Our consumer products business cannot generate sufficient cash flow, so a decline in Solana's value could hurt our ability to satisfy financial obligations.
- NewRisks Relating to Investing in Solana
We face other risks related to our Solana treasury strategy
Our Solana strategy subjects us to enhanced regulatory uncertainty, potential litigation risks regarding smart contracts, and changing political administrations.
- NewRisks Relating to Investing in Solana
SOL faces unique technical, governance and concentration risks that could materially affect its long-term viability
The Solana Network has suffered historical outages and uses a novel consensus mechanism that could experience structural flaws or network forks.
- NewRisks Relating to Investing in Solana
Solana validators are relatively small in number, which may lead to coordinated censorship
High infrastructure demands for Solana validators create concentration risks, potentially leading to coordinated censorship and delayed transactions.
- NewRisks Relating to Investing in Solana
Our Solana validator reward yield is expected to decline over time and could have a material adverse effect on our financial results
Solana's validator reward yield is expected to decline by 15% each year until it reaches a long-term rate of 1.5%.
- NewRisks Relating to Investing in Solana
Our SOL treasury strategy is dependent on the Solana Foundation and core development team
Our Solana strategy depends on the Solana Foundation and a small group of core developers for governance and technical direction.
Dropped
- DroppedRisks Related to Upexi
Increases in costs, disruption of supply or shortage of raw materials could harm our business
- DroppedRisks Relating to Our Business and Industry
We have limited supply sources, and price increases or supply shortages of key raw materials could materially and adversely affect our business, financial condition and results of operations
- DroppedRisks Relating to Our Business and Industry
Loss of key contracts with our suppliers, renegotiation of such agreements on less favorable terms or other actions these third parties may take could harm our business
- DroppedRisks Relating to Our Business and Industry
There is limited availability of clinical studies
- DroppedRisks Relating to Our Business and Industry
We may be unable to attract and retain independent distributors for our products
- DroppedRisks Relating to Our Business and Industry
competition in the market
- DroppedRisks Related to the CBD Industry
Laws and regulations affecting the CBD industry are evolving under the Farm Bill, and changes to applicable regulations may materially affect our future operations in the CBD market
- DroppedRisks Related to the CBD Industry
Unfavorable interpretations of laws governing hemp processing activities could subject us to enforcement or other legal proceedings and limit our business and prospects
- DroppedRisks Related to the CBD Industry
Costs associated with compliance with various laws and regulations could negatively impact our financial results
- DroppedRisks Related to the CBD Industry
Uncertainty caused by potential changes to legal regulations could impact the use and acceptance of CBD products
- DroppedRisks Related to the CBD Industry
If we fail to obtain necessary permits, licenses and approvals under applicable laws and regulations, our business and plan of operations may be adversely impacted
Increases in costs or shortages of raw materials like industrial hemp and pectin could harm business.
- DroppedRisks Related to the CBD Industry
Potential future international expansion of our business could expose us to additional regulatory risks and compliance costs
- DroppedRisks Related to the CBD Industry
The market for health and wellness products is highly competitive. If we are unable to compete effectively in the market, our business and operating results could be materially and adversely affected
- DroppedRisks Relating to Investing in Solana
Our Management relies upon the advice of an asset manager through an asset management agreement to assist in building a narrowly focused investment strategy and the execution of the Company’s strategy and may not yield the desired return
Reworded
- 67% rewrittenRisks Related to Upexi
We will incur increased costs and demands upon management as a result of complying with the laws and regulations affecting public companies, which could adversely affect our operating results
Minor capitalization changes of common stock terms.
- 49% rewrittenRisks Relating to Investing in Solana
We may use the net proceeds from any offering by the Company to purchase additional Solana, the price of which has been, and will likely continue to be, highly volatile
Added the term 'Momentum pricing' at the end of the risk description.
- 47% rewrittenRisks Related to Upexi
Our failure to meet the continuing listing requirements of the NASDAQ Capital Market could result in a delisting of our securities
Capitalization changes from 'Common Stock' to 'common stock'.
Was: Our failure to meet the continuing listing requirements of the NASDAQ Capital Market could result in a de-listing of our securities
- 28% rewrittenRisks Relating to Investing in Solana
Our Solana holdings are less liquid than our existing cash and cash equivalents and may not be able to serve as a source of liquidity for us to the same extent as cash and cash equivalents
No substantive textual changes made between the prior and current year.
All 46 risk factors
Headings as the filing states them, in filing order.
Risks Related to Upexi
- 01Upexi does not anticipate paying any dividends on its common stock
- 02You may experience additional dilution in the future
- 03Shares eligible for future sale may adversely affect the market
- 04Our limited operating history makes it difficult for potential investors to evaluate our business prospects and management
- 05If we are unable to protect our intellectual property rights, our competitive position could be harmed
- 06We may not be able to effectively manage growth
- 07Our management may not be able to control costs in an effective or timely manner
- 08We expect our quarterly financial results to fluctuate
- 09We are subject to the reporting requirements of U.S. federal securities laws, which can be expensive
- 10We may incur significant costs and require significant management resources to evaluate our internal control over financial reporting as required under Section 404 of the Sarbanes-Oxley Act, and any failure to comply or any adverse result from such evaluation may have an adverse effect on our stock price
- 11Our failure to meet the continuing listing requirements of the NASDAQ Capital Market could result in a delisting of our securities47% rewritten
- 12We will incur increased costs and demands upon management as a result of complying with the laws and regulations affecting public companies, which could adversely affect our operating results67% rewritten
- 13We are eligible to be treated as a “smaller reporting company” within the meaning of the Securities Act, and we cannot be certain if the reduced disclosure requirements applicable to smaller reporting companies will make our common stock less attractive to investorsnew
Risks Relating to Our Business and Industry
- 14We operate in a highly competitive environment, and if we are unable to compete with our competitors, our business, financial condition, results of operations, cash flows and prospects could be materially adversely affected
- 15Unfavorable publicity or consumer perception of our products or similar products developed and distributed by other companies could have a material adverse effect on our reputation, which could result in decreased sales and fluctuations in our business, financial condition and results of operations
- 16Our failure to appropriately and timely respond to changing consumer preferences and demand for new products could significantly harm our customer relationships and have a material adverse effect on our business, financial condition and results of operations
- 17Future acquisitions or strategic investments and partnerships could be difficult to identify and integrate with our business, disrupt our business, and adversely affect our financial condition and results of operations
- 18Failure to successfully integrate acquired businesses and their products and other assets into our Company, or if integrated, failure to further our business strategy, may result in our inability to realize any benefit from such acquisition
- 19The failure to attract and retain key employees could hurt our business
- 20We face substantial risk of product liability claims and potential adverse product publicity
- 21We could incur obligations resulting from the activities of our independent distributors
- 22If our independent distributors’ failure to comply with applicable advertising laws and regulations could adversely affect our financial conditions and results of operations
Risks Relating to Investing in Solana
- 23The launch of central bank digital currencies (“CBDCs”) may adversely impact our business
- 24Absent federal regulations, there is a possibility that Solana may be classified as a “security.” Any classification of Solana as a “security” would subject us to additional regulation and could materially impact the operation of our business
- 25If we were deemed to be an investment company under the 1940 Act, applicable restrictions likely would make it impractical for us to continue segments of our business as currently contemplated
- 26We may be subject to regulatory developments related to crypto assets and crypto asset markets, which could adversely affect our business, financial condition, and results of operations
- 27We may use the net proceeds from any offering by the Company to purchase additional Solana, the price of which has been, and will likely continue to be, highly volatile49% rewritten
- 28Fluctuations in the price of Solana may significantly influence the market price of our common stocknew
- 29A significant decrease in the market value of our Solana could adversely affect our ability to satisfy our financial obligationsnew
- 30Our Solana holdings are less liquid than our existing cash and cash equivalents and may not be able to serve as a source of liquidity for us to the same extent as cash and cash equivalents28% rewritten
- 31We are not subject to legal and regulatory obligations that apply to investment companies such as mutual funds and exchange-traded funds, or to obligations applicable to investment advisers
- 32significant regulatory scrutiny, investigations, fines, penalties, and other legal, regulatory, contractual and financial exposure
- 33Until recently, our business focus was as a brand owner specializing in the development, manufacturing, and distribution of consumer products. We reach consumers through our direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon
- 34If the digital asset award or transaction fees for recording transactions on the Solana network are not sufficiently high to incentivize validators may demand high transaction fees, which could negatively impact the value of SOL and the value of the shares
- 35A reduction in the digital assets staked by validators on the Solana network could increase the likelihood of a malicious actor or botnet (a volunteer or hacked collection of computers controlled by networked software coordinating the actions of the computers) obtaining control
- 36Our trading orders may not be timely executed
- 37Competition from other companies staking and utilizing Solana in their treasury plans
- 38Competition from central bank digital currencies (“CBDCs”) and emerging payments initiatives involving financial institutions could adversely affect the price of SOL and other digital assets
- 39Competition from the emergence or expansion of other digital assets may negatively influence the price of SOL and have an adverse impact on the value of the shares
- 40We may fail to develop and execute successful investment or trading strategies
- 41We may make, or otherwise be subject to, trade errors
- 42We face other risks related to our Solana treasury strategynew
- 43SOL faces unique technical, governance and concentration risks that could materially affect its long-term viabilitynew
- 44Solana validators are relatively small in number, which may lead to coordinated censorshipnew
- 45Our Solana validator reward yield is expected to decline over time and could have a material adverse effect on our financial resultsnew
- 46Our SOL treasury strategy is dependent on the Solana Foundation and core development teamnew
Other Upexi 10-Ks
- 2025 10-K risk factors
52 risks, 21 new since the prior year. Upexi faces significant new strategic risks centering on cryptocurrency investments, specifically holding Solana as a treasury asset. Regulatory uncertainty regarding whether Solana constitutes a security under federal law could severely impact the business. Potential classification under the Investment Company Act of 1940 could make operations impractical.
Filed Sep 24, 2025 - 2024 10-K risk factors
31 risks. Upexi faces intense competition in the hemp-based and CBD product market against better-resourced rivals.
Filed Dec 16, 2024
About this page
Item 1A of the 10-K on EDGAR was split into its risk factors and, where the company's previous 10-K is on file, each heading was matched to last year's and the text compared word for word. The headings are the filing's own. The one-line readings and the overview were written by a language model from the text of the new, dropped, and rewritten risks; they refer to risks by position and cannot misquote a heading.